Virus-like particles (VLPs) are multimeric nanostructures composed of one or more structural
proteins of a virus in the absence of genetic material. Having similar morphology to natural …

Emerging viruses pose a major threat to humans and livestock with global public health and
economic burdens. Vaccination remains an effective tool to reduce this threat, and yet, the …

Viral nanoparticles (VNPs) are self-assembling, adaptable delivery systems for vaccines and
other therapeutic agents used in a variety of biomedical applications. The potential of …

Virus-like particles (VLPs) structurally mimic the viral capsid and have therefore been
extensively, and quite successfully, used as vaccine and viral serology reagents. The ability …

Virus-like particles (VLPs) are formed by viral structural proteins that, when overexpressed,
spontaneously self-assemble into particles that are antigenically indistinguishable from …

New nanocarrier technologies are emerging, and they have great potential for improving
drug delivery, targeting efficiency and bioavailability. Virus-like particles (VLPs) are natural …

Viruses and the recombinant protein cages assembled from their structural proteins, known
as virus‐like particles (VLPs), have gained wide interest as tools in biotechnology and …

Virus-like particles (VLPs) derived from viral nucleocapsids are an important class of
nanoparticles. The structure, uniformity, stability, and function of these VLPs have attracted …

Virus-like particles (VLPs) have natural structural antigens similar to those found in viruses,
making them valuable in vaccine immunization. Furthermore, VLPs have demonstrated …

Virus-like particles (VLPs) have become key tools in biology, medicine and even
engineering. After their initial use to resolve viral structures at the atomic level, VLPs were …